From March 17th to 19th, 2022, Expomed 2022 was successfully held in Istanbul, Turkey. This conference attracted more than 600 companies from all over the world to participate in the exhibition, and the number of exhibitors reached 35,000. Everyone gathered to discuss the post-epidemic medical technology trends and share innovations and ideas. Pushkang brought a full set of POCT solutions to the conference.
The POCT platform based on centrifugal microfluidics technology, including coagulation, biochemistry, luminescence and molecular POCT, has been welcomed by many dealers and teachers since its exhibition. They have come to our department to discuss and cooperate, laying a good foundation for our department to expand the Middle East market.
The Turkish agent said Pashkang' s POCT solution would be a good supplement for users in different application scenarios in Turkey and hoped to be introduced as soon as possible to contribute to the overall medical level in Turkey.
This exhibition makes us deeply appreciate the charm of the Turkish Medical Exhibition, and provides a good platform for us to communicate with international friends and promote cooperation. The customers ' favor of Pushkang products in this international exhibition further proves that the POCT solution of Pushkang centrifugal microfluidics technology platform is not only applicable to the domestic market, but also has excellent adaptability to the overseas market. We believe that through different forms of overseas platform display and communication, there will be more international customers who understand Pushcon Biotechnology in the future. We will also work with more international medical companies to contribute to the international IVD industry.
The first appearance of the Turkish exhibition means that Pushkang has officially entered the Middle East market and has taken a historic step in opening up the international market. We will continue to strive to open up more international markets, adhere to the mission of "Accessible testing health at your side" and strive for the development of global human health care.
Post time: May-05-2022